Abraxis BioScience Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Revenue | 77.6 | 82.1 | 90.8 | 241.0 | 242.5 |
| Cost of Goods Sold | 9.9 | 8.6 | 8.3 | 96.6 | 85.7 |
| Gross Profit | 67.7 | 73.5 | 82.5 | 144.4 | 156.9 |
| Gross Profit Margin | 87.2% | 89.5% | 90.9% | 59.9% | 64.7% |
| SG&A Expense | 163.8 | 62.7 | 76.5 | 125.5 | 97.0 |
| Depreciation & Amortization | (7.3) | 13.1 | 12.6 | 26.2 | 24.8 |
| Operating Income | (88.8) | (2.2) | (6.6) | (7.3) | 35.0 |
| Operating Margin | -- | -- | -- | -- | 14.4% |
| Nonoperating Income | 4.8 | 6.8 | 4.4 | 1.0 | 0.8 |
| Nonoperating Expenses | -- | -- | 0.1 | 3.9 | 5.1 |
| Income Before Taxes | (83.9) | 4.3 | (1.4) | (9.5) | 32.3 |
| Income Taxes | 0.2 | 0.0 | 3.8 | (1.1) | 9.3 |
| Net Income After Taxes | (84.1) | 4.3 | (5.2) | (8.4) | 23.1 |
| Continuing Operations | (84.1) | 4.3 | (5.2) | (8.4) | 23.1 |
| Discontinued Operations | -- | -- | -- | -- | -- |
| Total Operations | (84.1) | 4.3 | (5.2) | (8.4) | 23.1 |
| Total Net Income | (84.1) | 4.3 | (5.2) | (8.4) | 23.1 |
| Net Profit Margin | -- | 5.2% | -- | -- | 9.5% |
| Diluted EPS from Total Net Income ($) | (2.11) | 0.11 | (1.04) | (0.05) | 0.14 |
| Dividends per Share | -- | -- | -- | -- | -- |
This data is provided as per license from EDGAR Online
